MedPath

Salivary C- Reactive Protein, Mean Platelet Volume and Neutrophil Lymphocyte Ratio as Diagnostic Markers for Neonatal Sepsis

Conditions
Neonatal Sepsis
Interventions
Diagnostic Test: Salivary CRP
Registration Number
NCT04800445
Lead Sponsor
Cairo University
Brief Summary

To evaluate reliability of salivary C-reactive protein ,mean platelet volume , neutrophil -lymphocyte ratio , and platelet lymphocyte ratio in diagnosis of neonatal sepsis

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
    • Full term neonates of both genders from birth to the 28th day of life diagnosed with sepsis by history, clinical findings, laboratory findings, and blood culture. The clinical findings included the presence of three or more of the following:
  • (1) temperature instability (hypothermia, hyperthermia) .
  • (2) respiratory alterations (grunting, intercostal retractions, apnea, tachypnea, cyanosis) .
  • (3) cardiovascular alterations (bradycardia, tachycardia, poor perfusion, hypotension) .
  • (4) neurologic alterations (hypotonia, lethargy, seizures)
  • (5) gastrointestinal alterations (feeding intolerance, abdominal distension). CRP values >10 mg/L were considered to be positive.
Exclusion Criteria
    • Preterm neonates .
  • Neonates with CNS malformations, metabolic disorders, chromosomal abnormalities, intrauterine growth restriction, or birth asphyxia were excluded from the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Healthy fullterm neonatesSalivary CRP-
Case group of fullterm neonates with neonatal sepsisSalivary CRP-
Primary Outcome Measures
NameTimeMethod
Salivary c reactive protein in neonatal sepsis28 days

Salivary C reactive protein of value as non invasive procedure in diagnosis of neonatal sepsis

Secondary Outcome Measures
NameTimeMethod
Mean platelet volume28 days

Asses the validity of Mean Platlet Volume as marker of neonatal sepsis which is equal about ( 9 - 11.4 ) in septic group and about ( 7.5 - 8.5 ) in control group

Trial Locations

Locations (1)

Faculty of medicine

🇪🇬

Cairo, Almanyal, Egypt

© Copyright 2025. All Rights Reserved by MedPath